Press releases
- STAAR Surgical to Participate in Goldman Sachs 45th Annual Global Healthcare Conference
- STAAR Surgical Reports First Quarter 2024 Results
- STAAR Surgical Announces Milestone Strategic Agreement in U.S. with IQ Laser Vision
- STAAR Surgical Strengthens Leadership Team with Appointments of Nancy Sabin as Chief Marketing Officer and Nathaniel Sisitsky as General Counsel
- STAAR Surgical to Report First Quarter Results on May 7, 2024
- STAAR Surgical Announces Preliminary Net Sales for First Quarter 2024
- STAAR Surgical Celebrates Three Million Lens Milestone at ASCRS Meeting, Unveils New EVO ICL Data and Latest Innovation for 2024
- STAAR Surgical Celebrates Three Million Implantable Collamer® Lenses
More ▼
Key statistics
As of last trade, STAAR Surgical Co (SR3:FRA) traded at 35.71, 39.49% above the 52 week low of 25.60 set on Feb 06, 2024.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 35.71 |
---|---|
High | 35.71 |
Low | 35.71 |
Bid | 35.71 |
Offer | 36.11 |
Previous close | 36.95 |
Average volume | 77.86 |
---|---|
Shares outstanding | 49.13m |
Free float | 48.85m |
P/E (TTM) | 131.28 |
Market cap | 2.00bn USD |
EPS (TTM) | 0.3093 USD |
Data delayed at least 15 minutes, as of Jun 10 2024 07:10 BST.
More ▼